Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

328
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
328
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

730
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
730
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

837
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
837
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

419
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
419
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

274
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
274
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

416
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
416

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Less severe endothelial injury and vascular pathway activation in SARS-CoV-2 Omicron variant compared to Alpha.

Scientific reports·2026
Same author

Hypoimmunogenic iPSC-derived hepatic organoids featuring a functional vascular network.

Scientific reports·2026
Same author

Anti-nephrin antibodies are not enriched in patients with primary and posttransplant recurrent podocytopathies.

The Journal of clinical investigation·2026
Same author

Investigating the role of serum NfL, FGF21, NCAM1 and GDF15 as disease biomarkers for Charcot-Marie-Tooth type 2A.

Scientific reports·2026
Same author

Holding cancer in line: the role of the electron transport chain in tumor-associated macrophages.

Frontiers in immunology·2026
Same author

Prospective Cohort Study of Obinutuzumab in Rituximab-Resistant Primary Membranous Nephropathy.

Kidney international reports·2026
Same journal

RETRACTED: Kim et al. The Angiogenesis Inhibitor ALS-L1023 from Lemon-Balm Leaves Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease Through Regulating the Visceral Adipose-Tissue Function. <i>Int. J. Mol. Sci.</i> 2017, <i>18</i>, 846.

International journal of molecular sciences·2026
Same journal

Correction: Mahmud et al. Thymoquinone Attenuates NF-κβ Signalling Activation in Retinal Pigment Epithelium Cells Under AMD-Mimicking Conditions. <i>Int. J. Mol. Sci.</i> 2025, <i>26</i>, 11473.

International journal of molecular sciences·2026
Same journal

Correction: Borovikov et al. The Twisting and Untwisting of Actin and Tropomyosin Filaments Are Involved in the Molecular Mechanisms of Muscle Contraction, and Their Disruption Can Result in Muscle Disorders. <i>Int. J. Mol. Sci</i>. 2025, <i>26</i>, 6705.

International journal of molecular sciences·2026
Same journal

Correction: Molagoda et al. Flavonoid Glycosides from <i>Ziziphus jujuba</i> var. <i>inermis</i> (Bunge) Rehder Seeds Inhibit α-Melanocyte-Stimulating Hormone-Mediated Melanogenesis. <i>Int. J. Mol. Sci.</i> 2021, <i>22</i>, 7701.

International journal of molecular sciences·2026
Same journal

Correction: Guo et al. Integrated Transcriptomic and Metabolomic Analysis Reveals the Molecular Regulatory Mechanism of Flavonoid Biosynthesis in Maize Roots Under Lead Stress. <i>Int. J. Mol. Sci.</i> 2024, <i>25</i>, 6050.

International journal of molecular sciences·2026
Same journal

Correction: Chang et al. Improvement of Carbon Tetrachloride-Induced Acute Hepatic Failure by Transplantation of Induced Pluripotent Stem Cells Without Reprogramming Factor c-Myc. <i>Int. J. Mol. Sci.</i> 2012, <i>13</i>, 3598-3617.

International journal of molecular sciences·2026
See all related articles

Related Experiment Video

Updated: Jan 6, 2026

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly
06:09

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly

Published on: August 20, 2019

16.7K

KRIT1 Deficiency Promotes Aortic Endothelial Dysfunction.

Francesco Vieceli Dalla Sega1, Raffaella Mastrocola2,3, Giorgio Aquila4

  • 1Maria Cecilia Hospital, GVM Care & Research, 48033 Cotignola (RA), Italy. vclfnc@unife.it.

International Journal of Molecular Sciences
|October 9, 2019
PubMed
Summary
This summary is machine-generated.

Loss of Krev interaction trapped protein 1 (KRIT1) function promotes endothelial dysfunction and atherosclerosis. This suggests KRIT1 deficiency may increase susceptibility to atherosclerotic lesions beyond Cerebral Cavernous Malformation.

Keywords:
ICAM-1KRIT1Notch1ROSVCAM-1atherosclerosiscerebral cavernous malformation (CCM)endothelial dysfunction (ED)notch signalingoxidative stress

More Related Videos

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.7K
Murine Model of Thoracic Aortic Dissection Induced by Oral &#946;-Aminopropionitrile and Subcutaneous Angiotensin II Infusion
05:31

Murine Model of Thoracic Aortic Dissection Induced by Oral β-Aminopropionitrile and Subcutaneous Angiotensin II Infusion

Published on: May 16, 2025

757

Related Experiment Videos

Last Updated: Jan 6, 2026

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly
06:09

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly

Published on: August 20, 2019

16.7K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.7K
Murine Model of Thoracic Aortic Dissection Induced by Oral &#946;-Aminopropionitrile and Subcutaneous Angiotensin II Infusion
05:31

Murine Model of Thoracic Aortic Dissection Induced by Oral β-Aminopropionitrile and Subcutaneous Angiotensin II Infusion

Published on: May 16, 2025

757

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Endothelial Cell Biology

Background:

  • Loss-of-function mutations in Krev interaction trapped protein 1 (KRIT1) cause Cerebral Cavernous Malformation (CCM).
  • KRIT1 modulates redox-sensitive pathways, suggesting roles beyond CCM in oxidative stress and inflammation.
  • KRIT1's role in endothelial dysfunction and atherosclerosis remains unclear.

Purpose of the Study:

  • To investigate if KRIT1 loss-of-function predisposes to endothelial dysfunction and atherosclerosis.
  • To determine the impact of KRIT1 deficiency on endothelial cell responses to oxidative stress and inflammation.

Main Methods:

  • KRIT1 was silenced in human endothelial cells (HAECs, HCAECs, HUVECs).
  • Pro-inflammatory markers (VCAM-1, ICAM-1) and apoptosis were assessed.
  • Notch1 activation and redox homeostasis were evaluated.
  • Atherosclerosis was studied in KRIT1+/- mice fed a high-fructose diet.

Main Results:

  • KRIT1 silencing increased VCAM-1 and ICAM-1 expression and TNF-α-induced apoptosis in endothelial cells.
  • These effects were linked to reduced Notch1 activation and altered redox homeostasis.
  • KRIT1+/- mice showed increased VCAM-1 and fat accumulation in atherosclerotic regions.
  • Antioxidant treatment rescued KRIT1-silencing-induced effects.

Conclusions:

  • KRIT1 deficiency promotes endothelial dysfunction.
  • KRIT1 plays a role in protecting against oxidative stress and inflammation in endothelial cells.
  • KRIT1 may be implicated in genetic susceptibility to atherosclerosis development.